243 related articles for article (PubMed ID: 15212879)
1. Transdermal delivery of mixnoxidil with block copolymer nanoparticles.
Shim J; Seok Kang H; Park WS; Han SH; Kim J; Chang IS
J Control Release; 2004 Jul; 97(3):477-84. PubMed ID: 15212879
[TBL] [Abstract][Full Text] [Related]
2. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
3. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
[TBL] [Abstract][Full Text] [Related]
5. Transcutol containing vesicles for topical delivery of minoxidil.
Mura S; Manconi M; Valenti D; Sinico C; Vila AO; Fadda AM
J Drug Target; 2011 Apr; 19(3):189-96. PubMed ID: 20446805
[TBL] [Abstract][Full Text] [Related]
6. In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl beta-cyclodextrin/minoxidil complex.
Kwon TK; Kim JC
Int J Pharm; 2010 Jun; 392(1-2):268-73. PubMed ID: 20362653
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
Shenoy DB; Amiji MM
Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
[TBL] [Abstract][Full Text] [Related]
8. Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication.
Takeuchi I; Hida Y; Makino K
Biomed Mater Eng; 2018; 29(2):217-228. PubMed ID: 29457595
[TBL] [Abstract][Full Text] [Related]
9. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin.
Tata S; Weiner N; Flynn G
J Pharm Sci; 1994 Oct; 83(10):1508-10. PubMed ID: 7884676
[TBL] [Abstract][Full Text] [Related]
10. Follicular and percutaneous penetration pathways of topically applied minoxidil foam.
Blume-Peytavi U; Massoudy L; Patzelt A; Lademann J; Dietz E; Rasulev U; Garcia Bartels N
Eur J Pharm Biopharm; 2010 Nov; 76(3):450-3. PubMed ID: 20600888
[TBL] [Abstract][Full Text] [Related]
11. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
[TBL] [Abstract][Full Text] [Related]
12. Influence of application time and formulation reapplication on the delivery of minoxidil through hairless mouse skin as measured in Franz diffusion cells.
Tsai JC; Flynn GL; Weiner N; Ferry JJ
Skin Pharmacol; 1994; 7(5):270-7. PubMed ID: 8054209
[TBL] [Abstract][Full Text] [Related]
13. After-rinsing hair growth promotion of minoxidil-containing amino alpha-cyclodextrins.
Kim JC; Kim MD
J Microbiol Biotechnol; 2007 Dec; 17(12):1965-9. PubMed ID: 18167443
[TBL] [Abstract][Full Text] [Related]
14. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
[TBL] [Abstract][Full Text] [Related]
15. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size.
Sonavane G; Tomoda K; Sano A; Ohshima H; Terada H; Makino K
Colloids Surf B Biointerfaces; 2008 Aug; 65(1):1-10. PubMed ID: 18499408
[TBL] [Abstract][Full Text] [Related]
16. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation.
Song CK; Balakrishnan P; Shim CK; Chung SJ; Chong S; Kim DD
Colloids Surf B Biointerfaces; 2012 Apr; 92():299-304. PubMed ID: 22205066
[TBL] [Abstract][Full Text] [Related]
17. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
19. Monolayer-protected gold nanoparticles by the self-assembly of micellar poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymer.
Azzam T; Eisenberg A
Langmuir; 2007 Feb; 23(4):2126-32. PubMed ID: 17279704
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.
López-Pinto JM; González-Rodríguez ML; Rabasco AM
Int J Pharm; 2005 Jul; 298(1):1-12. PubMed ID: 15896932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
